| Dr James John Hakim, MD | |
|
571 Central Ave Ste 112, New Providence, NJ 07974-1547 | |
| (908) 464-7300 | |
| (908) 464-7350 |
| Full Name | Dr James John Hakim |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 38 Years |
| Location | 571 Central Ave Ste 112, New Providence, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457411019 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | MA05000500 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Atlantic Home Care & Hospice | Morristown, NJ | Home health agency |
| Overlook Medical Center | Summit, NJ | Hospital |
| Morristown Medical Center | Morristown, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Primary Care Partners Llc | 2860665809 | 76 |
News Archive
DiagnoCure, Inc., a Quebec life sciences company that develops and commercializes high‐value cancer diagnostic tests, announced today that the US Food and Drug Administration (FDA) has approved Gen-Probe's PROGENSA PCA3 (Prostate Cancer Antigen 3) assay, the first molecular test to help determine the need for repeat prostate biopsies in men who have had a previous negative biopsy.
Sanofi Pasteur, the vaccines division of the sanofi-aventis Group, has been awarded a three-year contract for $56.94 million by the U.S. Department of Health and Human Services (HHS) to maintain flocks to enable manufacturing pandemic influenza vaccine at full capacity on a year-round basis.
A new publication from Dr Eamon Laird and Professor Rose Anne Kenny, School of Medicine, and the Irish Longitudinal Study on Ageing (TILDA), in collaboration with Professor Jon Rhodes at University of Liverpool, highlights the association between vitamin D levels and mortality from COVID-19.
Teva Pharmaceuticals USA, the world's leading generic pharmaceutical company, today announced the start of its "Patient First" project as part of the Year of Affordable Healthcare campaign. The initiative, available at: www.yearofaffordablehealth.com/patients, features a first-hand perspective of everyday Americans as they struggle with the enormous and sometimes insurmountable expense of paying for their prescription medicines.
› Verified 4 days ago
| Entity Name | New Providence Internal Medicine Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972657195 PECOS PAC ID: 5092723486 Enrollment ID: O20060327000497 |
News Archive
DiagnoCure, Inc., a Quebec life sciences company that develops and commercializes high‐value cancer diagnostic tests, announced today that the US Food and Drug Administration (FDA) has approved Gen-Probe's PROGENSA PCA3 (Prostate Cancer Antigen 3) assay, the first molecular test to help determine the need for repeat prostate biopsies in men who have had a previous negative biopsy.
Sanofi Pasteur, the vaccines division of the sanofi-aventis Group, has been awarded a three-year contract for $56.94 million by the U.S. Department of Health and Human Services (HHS) to maintain flocks to enable manufacturing pandemic influenza vaccine at full capacity on a year-round basis.
A new publication from Dr Eamon Laird and Professor Rose Anne Kenny, School of Medicine, and the Irish Longitudinal Study on Ageing (TILDA), in collaboration with Professor Jon Rhodes at University of Liverpool, highlights the association between vitamin D levels and mortality from COVID-19.
Teva Pharmaceuticals USA, the world's leading generic pharmaceutical company, today announced the start of its "Patient First" project as part of the Year of Affordable Healthcare campaign. The initiative, available at: www.yearofaffordablehealth.com/patients, features a first-hand perspective of everyday Americans as they struggle with the enormous and sometimes insurmountable expense of paying for their prescription medicines.
› Verified 4 days ago
| Entity Name | Primary Care Partners Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083900526 PECOS PAC ID: 2860665809 Enrollment ID: O20111108000032 |
News Archive
DiagnoCure, Inc., a Quebec life sciences company that develops and commercializes high‐value cancer diagnostic tests, announced today that the US Food and Drug Administration (FDA) has approved Gen-Probe's PROGENSA PCA3 (Prostate Cancer Antigen 3) assay, the first molecular test to help determine the need for repeat prostate biopsies in men who have had a previous negative biopsy.
Sanofi Pasteur, the vaccines division of the sanofi-aventis Group, has been awarded a three-year contract for $56.94 million by the U.S. Department of Health and Human Services (HHS) to maintain flocks to enable manufacturing pandemic influenza vaccine at full capacity on a year-round basis.
A new publication from Dr Eamon Laird and Professor Rose Anne Kenny, School of Medicine, and the Irish Longitudinal Study on Ageing (TILDA), in collaboration with Professor Jon Rhodes at University of Liverpool, highlights the association between vitamin D levels and mortality from COVID-19.
Teva Pharmaceuticals USA, the world's leading generic pharmaceutical company, today announced the start of its "Patient First" project as part of the Year of Affordable Healthcare campaign. The initiative, available at: www.yearofaffordablehealth.com/patients, features a first-hand perspective of everyday Americans as they struggle with the enormous and sometimes insurmountable expense of paying for their prescription medicines.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr James John Hakim, MD Lb #7550, P.o. Box 95000, Philadelphia, PA 19195-7550 Ph: (844) 362-1735 | Dr James John Hakim, MD 571 Central Ave Ste 112, New Providence, NJ 07974-1547 Ph: (908) 464-7300 |
News Archive
DiagnoCure, Inc., a Quebec life sciences company that develops and commercializes high‐value cancer diagnostic tests, announced today that the US Food and Drug Administration (FDA) has approved Gen-Probe's PROGENSA PCA3 (Prostate Cancer Antigen 3) assay, the first molecular test to help determine the need for repeat prostate biopsies in men who have had a previous negative biopsy.
Sanofi Pasteur, the vaccines division of the sanofi-aventis Group, has been awarded a three-year contract for $56.94 million by the U.S. Department of Health and Human Services (HHS) to maintain flocks to enable manufacturing pandemic influenza vaccine at full capacity on a year-round basis.
A new publication from Dr Eamon Laird and Professor Rose Anne Kenny, School of Medicine, and the Irish Longitudinal Study on Ageing (TILDA), in collaboration with Professor Jon Rhodes at University of Liverpool, highlights the association between vitamin D levels and mortality from COVID-19.
Teva Pharmaceuticals USA, the world's leading generic pharmaceutical company, today announced the start of its "Patient First" project as part of the Year of Affordable Healthcare campaign. The initiative, available at: www.yearofaffordablehealth.com/patients, features a first-hand perspective of everyday Americans as they struggle with the enormous and sometimes insurmountable expense of paying for their prescription medicines.
› Verified 4 days ago
Dr. Khimya I Vaswani, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1806 Springfield Ave, New Providence, NJ 07974 Phone: 973-912-0104 Fax: 973-376-7040 | |
Robert John Mich, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 571 Central Ave Ste 115, Associates In Cardiovascular Disease Llc, New Providence, NJ 07974 Phone: 908-464-4200 Fax: 908-464-1332 | |
John Patrick Farry, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 571 Central Ave Ste 115, Associates In Cardiovascular Disease Llc, New Providence, NJ 07974 Phone: 908-464-4200 Fax: 908-464-1332 | |
Robert L Rosenbaum, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 890 Mountain Ave, New Providence, NJ 07974 Phone: 908-277-8667 Fax: 908-277-8707 | |
David Bartov, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 571 Central Ave Ste 115, Associates In Cardiovascular Disease, New Providence, NJ 07974 Phone: 908-464-2000 Fax: 908-464-1332 | |
Dr. Sushmita Srivastav, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 535 Mountain Ave, New Providence, NJ 07974 Phone: 903-516-9245 Fax: 908-516-9265 |